CAS 1035438-80-2 Risedronic Acid-[d4] - Isotope / BOC Sciences

General Information
Catalog: BLP-005990
CAS: 1035438-80-2
Molecular Formula: C7H7D4NO7P2
Molecular Weight: 287.14

General Information

Catalog: BLP-005990

CAS: 1035438-80-2

Molecular Formula: C7H7D4NO7P2

Molecular Weight: 287.14

Chemical Structure

Description	An isotope labelled of Risedronic acid. Risedronic acid is a bisphosphonate used to strengthen bone and treat osteoporosis.
Synonyms	[1-Hydroxy-2-(3-pyridinyl)ethylidene]bis phosphonic Acid-d4; Actonel-d4; NE 58095-d4
IUPAC Name	[1-hydroxy-1-phosphono-2-(2,4,5,6-tetradeuteriopyridin-3-yl)ethyl]phosphonic acid
Related CAS	105462-24-6 (unlabelled)
Isomeric SMILES	[2H]C1=C(C(=C(N=C1[2H])[2H])CC(O)(P(=O)(O)O)P(=O)(O)O)[2H]
Canonical SMILES	C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
InChI	InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)/i1D,2D,3D,5D
InChI Key	IIDJRNMFWXDHID-RZIJKAHPSA-N
Melting Point	>190°C (dec.)
Purity	95% by HPLC; 98% atom D
Solubility	Soluble in Aqueous Base (Slightly), Water (Slightly)
Appearance	White to Off-white Solid
Storage	Store at-20°C

Risedronic Acid-[d4], a deuterated variant of risedronate primarily utilized in scientific research, offers diverse applications in the following realms:

Pharmacokinetic Studies: Employed in pharmacokinetic investigations, Risedronic Acid-[d4] plays a pivotal role in deciphering the absorption, distribution, metabolism, and excretion (ADME) dynamics of bisphosphonates within the body. By leveraging deuterium labeling, researchers can meticulously track the compound, enhancing insights into its bioavailability and metabolic pathways. This differentiation from non-labeled counterparts enables clearer apprehension of risedronate's pharmacokinetics.

Bone Metabolism Research: Researchers harness Risedronic Acid-[d4] to delve into the impact of bisphosphonates on bone metabolism in animal models. This compound facilitates the exploration of bisphosphonate mechanisms on bone resorption and formation. The deuterium-labeled feature offers intricate perspectives on the drug-bone tissue interactions, fostering the advancement of more potent osteoporosis therapies.

Drug Interaction Studies: In the realm of drug-drug interactions, Risedronic Acid-[d4] serves as a key player in elucidating the interplay between risedronate and other medications. Through the application of the labeled compound, researchers can disentangle it within complex mixtures, simplifying the investigation of its interactions with other drugs. This scrutiny is imperative for patients managing multiple medications, ensuring the safety and efficacy of their drug regimens.

Tracer for Mass Spectrometry: Within the domain of analytical chemistry, Risedronic Acid-[d4] shines as a tracer in mass spectrometry analyses, facilitating the quantification of risedronate levels in biological samples. The deuterium-labeled compound furnishes discernible mass signatures, augmenting the precision and sensitivity of the analysis. This utility proves indispensable for monitoring therapeutic risedronate levels in patients and conducting bioequivalence assessments.